Literature DB >> 16624842

Validation of the nerve axon reflex for the assessment of small nerve fibre dysfunction.

A Caselli1, V Spallone, G A Marfia, C Battista, C Pachatz, A Veves, L Uccioli.   

Abstract

OBJECTIVE: To validate nerve-axon reflex-related vasodilatation as an objective method to evaluate C-nociceptive fibre function by comparing it with the standard diagnostic criteria.
METHODS: Neuropathy was evaluated in 41 patients with diabetes (26 men and 15 women) without peripheral vascular disease by assessing the Neuropathy Symptom Score, the Neuropathy Disability Score (NDS), the vibration perception threshold (VPT), the heat detection threshold (HDT), nerve conduction parameters and standard cardiovascular tests. The neurovascular response to 1% acetylcholine (Ach) iontophoresis was measured at the forearm and at both feet by laser flowmetry. An age-matched and sex-matched control group of 10 healthy people was also included.
RESULTS: Significant correlations were observed between the neurovascular response at the foot and HDT (r(s) = -0.658; p<0.0001), NDS (r(s) = -0.665; p<0.0001), VPT (r(s) = -0.548; p = 0.0005), tibial nerve conduction velocity (r(s) = 0.631; p = 0.0002), sural nerve amplitude (r(s) = 0.581; p = 0.0002) and autonomic function tests. According to the NDS, in patients with diabetes who had mild, moderate or severe neuropathy, a significantly lower neurovascular response was seen at the foot than in patients without neuropathy and controls. A neurovascular response <50% was found to be highly sensitive (90%), with a good specificity (74%), in identifying patients with diabetic neuropathy.
CONCLUSION: Small-fibre dysfunction can be diagnosed reliably with neurovascular response assessment. This response is already reduced in the early stages of peripheral neuropathy, supporting the hypothesis that small-fibre impairment is an early event in the natural history of diabetic neuropathy.

Entities:  

Mesh:

Year:  2006        PMID: 16624842      PMCID: PMC2077635          DOI: 10.1136/jnnp.2005.069609

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  29 in total

1.  Primary nociceptive afferents mediate the blood flow dysfunction in non-glabrous (hairy) skin of type 2 diabetes: a new model for the pathogenesis of microvascular dysfunction.

Authors:  K B Stansberry; H R Peppard; L M Babyak; G Popp; P M McNitt; A I Vinik
Journal:  Diabetes Care       Date:  1999-09       Impact factor: 19.112

2.  The Thermocross: a simple tool for rapid assessment of thermal sensation thresholds.

Authors:  C Liniger; A Albeanu; J F Moody; J Richez; D Bloise; J P Assal
Journal:  Diabetes Res Clin Pract       Date:  1991-04       Impact factor: 5.602

Review 3.  Utility of skin biopsy in diabetic neuropathy.

Authors:  W R Kennedy; G Wendelschafer-Crabb
Journal:  Semin Neurol       Date:  1996-06       Impact factor: 3.420

Review 4.  Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. The Consensus Committee of the American Autonomic Society and the American Academy of Neurology.

Authors: 
Journal:  Neurology       Date:  1996-05       Impact factor: 9.910

5.  Components of variance for vibratory and thermal threshold testing in normal and diabetic subjects.

Authors:  D A Gelber; M A Pfeifer; V L Broadstone; E W Munster; M Peterson; J C Arezzo; H Shamoon; A Zeidler; R Clements; D A Greene
Journal:  J Diabetes Complications       Date:  1995 Jul-Sep       Impact factor: 2.852

6.  Reproducibility of parameters for assessment of diabetic neuropathy. The French Group for Research and Study of Diabetic Neuropathy.

Authors:  P Valensi; J R Attali; S Gagant
Journal:  Diabet Med       Date:  1993-12       Impact factor: 4.359

7.  Responses of the skin microcirculation to acetylcholine and sodium nitroprusside in patients with NIDDM.

Authors:  S J Morris; A C Shore; J E Tooke
Journal:  Diabetologia       Date:  1995-11       Impact factor: 10.122

8.  A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population.

Authors:  M J Young; A J Boulton; A F MacLeod; D R Williams; P H Sonksen
Journal:  Diabetologia       Date:  1993-02       Impact factor: 10.122

9.  Variability in function measurements of three sensory foot nerves in neuropathic diabetic patients.

Authors:  V M Donaghue; J M Giurini; B I Rosenblum; P N Weissman; A Veves
Journal:  Diabetes Res Clin Pract       Date:  1995-07       Impact factor: 5.602

10.  Differences in peripheral and autonomic nerve function measurements in painful and painless neuropathy. A clinical study.

Authors:  A Veves; M J Young; C Manes; A J Boulton
Journal:  Diabetes Care       Date:  1994-10       Impact factor: 19.112

View more
  11 in total

Review 1.  Microvascular dysfunction in the context of diabetic neuropathy.

Authors:  Alin Stirban
Journal:  Curr Diab Rep       Date:  2014       Impact factor: 4.810

2.  Laser Doppler imaging in the detection of peripheral neuropathy.

Authors:  Ben M W Illigens; Timo Siepmann; Joseph Roofeh; Christopher H Gibbons
Journal:  Auton Neurosci       Date:  2013-07-11       Impact factor: 3.145

3.  Further insight on A-wave in acute and chronic demyelinating neuropathies.

Authors:  Ferdinando Sartucci; Tommaso Bocci; Davide Borghetti; Giovanni Orlandi; Francesco Manfredonia; Luigi Murri; Fabio Giannini; Alessandro Rossi
Journal:  Neurol Sci       Date:  2010-06-18       Impact factor: 3.307

4.  Sensory loss, pains, motor deficit and axonal regeneration in length-dependent diabetic polyneuropathy.

Authors:  G Said; D Baudoin; K Toyooka
Journal:  J Neurol       Date:  2008-09-25       Impact factor: 4.849

5.  Diabetic neuropathy: a cross-sectional study of the relationships among tests of neurophysiology.

Authors:  Christopher H Gibbons; Roy Freeman; Aristidis Veves
Journal:  Diabetes Care       Date:  2010-08-30       Impact factor: 19.112

6.  Pharmacokinetic and pharmacodynamic drug interactions of carbamazepine and glibenclamide in healthy albino Wistar rats.

Authors:  S Prashanth; A Anil Kumar; B Madhu; N Rama; J Vidya Sagar
Journal:  J Pharmacol Pharmacother       Date:  2011-01

7.  Diabetic neuropathy and axon reflex-mediated neurogenic vasodilatation in type 1 diabetes.

Authors:  Maryam Nabavi Nouri; Ausma Ahmed; Vera Bril; Andrej Orszag; Eduardo Ng; Patti Nwe; Bruce A Perkins
Journal:  PLoS One       Date:  2012-04-17       Impact factor: 3.240

8.  Peripheral sensory neuropathy is associated with altered postocclusive reactive hyperemia in the diabetic foot.

Authors:  Alex L Barwick; John W Tessier; Xanne Janse de Jonge; James R Ivers; Vivienne H Chuter
Journal:  BMJ Open Diabetes Res Care       Date:  2016-07-07

9.  Transplantation of bone marrow-derived mesenchymal stem cells improves diabetic polyneuropathy in rats.

Authors:  Taiga Shibata; Keiko Naruse; Hideki Kamiya; Mika Kozakae; Masaki Kondo; Yutaka Yasuda; Nobuhisa Nakamura; Kimiko Ota; Takahiro Tosaki; Takashi Matsuki; Eitaro Nakashima; Yoji Hamada; Yutaka Oiso; Jiro Nakamura
Journal:  Diabetes       Date:  2008-08-26       Impact factor: 9.461

Review 10.  Laser Doppler Assessment of Vasomotor Axon Reflex Responsiveness to Evaluate Neurovascular Function.

Authors:  Marie Luise Kubasch; Anne Sophie Kubasch; Juliana Torres Pacheco; Sylvia J Buchmann; Ben Min-Woo Illigens; Kristian Barlinn; Timo Siepmann
Journal:  Front Neurol       Date:  2017-08-14       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.